Arcturus Therapeutics (ARCT) Holdings announced that the U.S. Food and Drug Administration has issued a “Study Can Proceed” notification for the Company’s Investigational New Drug application, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback